• Nenhum resultado encontrado

FTY720 in hematopoietic cell transplantation

N/A
N/A
Protected

Academic year: 2017

Share "FTY720 in hematopoietic cell transplantation"

Copied!
2
0
0

Texto

Loading

Referências

Documentos relacionados

Bone marrow -derived mesenchymal stem cells remain host-derived despite suc- cessful hematopoietic engraftment after allogeneic transplantation in patients w ith lysosomal

Guidelines of the Brazilian Society of Bone Marrow Transplantation on hematopoietic stem cell transplantation as a treatment for the autoimmune diseases systemic sclerosis

ease, and a second related donor allogeneic hematopoietic stem cell transplantation..

Pericardial effusion and cardiac tamponade: clinical manifestation of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.. David

Unrelated donor reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma.. Biol Blood

The฀patient฀underwent฀ABO-incompatible฀allogeneic฀ bone฀ marrow฀ transplantation฀ in฀ February,฀ 1997.฀ The฀ marrow฀ donor฀ was฀ his฀ HLA-identical฀

This study evaluated the influence of donor character- istics such as age, gender, CMV status, cell source, ABO compatibility and type of donor (matched related – MRD or

According to the decree, the allogeneic hematopoietic stem cell transplantation (HSCT) with related donor, of bone marrow, peripheral blood or umbilical cord blood,